Avenue Therapeutics enters $3.85M ATM equity offering agreement with H.C. Wainwright

AVENUE THERAPEUTICS, INC.

Company entered ATM offering agreement with H.C. Wainwright for up to $3,850,000 in common stock sales.
Manager receives 3.0% commission on gross proceeds; Company provides customary indemnification and contribution rights.
Offering is 'at the market' under Rule 415; Company may sell shares at its discretion over time.
Agreement terminates upon sale of all shares or earlier termination by either party on specified prior notice.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AVENUE THERAPEUTICS, INC. entered into At the Market Offering Agreement with H.C. Wainwright & Co. LLC valued at $3,850,000 (effective 2024-05-10).

Action: entry
Agreement: atm program
Counterparty: H.C. Wainwright & Co. LLC
Value: $3,850,000
Effective: 2024-05-10

Exact text from the filing

On May 10, 2024, Avenue Therapeutics, Inc. (the “ Company ”) entered into an At the Market Offering Agreement (the “ Offering Agreement ”) with H.C. Wainwright & Co. LLC (the “ Manager ”) under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock

View on SEC.gov

Browse all material agreements →

AVENUE THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-24-016081

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.